Treatment of muscle‐invasive and advanced bladder cancer in 2020
Patel V, Oh W, Galsky M. Treatment of muscle‐invasive and advanced bladder cancer in 2020. CA A Cancer Journal For Clinicians 2020, 70: 404-423. PMID: 32767764, DOI: 10.3322/caac.21631.Peer-Reviewed Original ResearchConceptsAdvanced bladder cancerCharacterization of bladder cancerBladder cancerMuscle-invasiveGenomic characterization of bladder cancerMolecular characterization of bladder cancerManagement of muscle-invasiveTreatment of muscle-invasiveMuscle-invasive bladder cancerFibroblast growth factor receptor inhibitorGrowth factor receptor inhibitorsCharacteristics of bladder cancerImmune checkpoint inhibitorsMolecular characteristics of bladder cancerPlatinum-based chemotherapyDevelopment of novel therapiesBladder cancer managementChanging treatment landscapeOptimal treatment approachPotential therapeutic vulnerabilitiesAntibody-drug conjugatesBladder cancer pathogenesisCheckpoint inhibitorsMutational burdenReceptor inhibitors
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply